Buy Compounded Semaglutide in Miami: Telehealth vs Local Clinics (2026)
Miami's wellness culture and body-conscious lifestyle have driven rapid growth in weight loss clinics — but most GLP-1 programs in Brickell, South Beach, and Coral Gables run $300–600/month. TRIMI delivers compounded semaglutide to any South Florida address for $99/month.
More on Local Access
Why Miami Residents Choose Telehealth for GLP-1
Miami is one of the most appearance-conscious cities in the United States, which has created a booming market for GLP-1 weight loss programs. Brickell, South Beach, Aventura, and Coral Gables are all home to premium wellness clinics offering semaglutide and tirzepatide — but at prices that reflect South Florida's luxury real estate costs and high clinic overhead. Most in-person programs in Miami charge $300–600/month for the same compounded semaglutide that TRIMI delivers for $99/month.
Miami-Dade County has a large uninsured population — approximately 18% of adults lack health coverage, compared to the national average of around 8%. For these residents, brand-name Wegovy at over $1,000/month is completely inaccessible, and even the lower-priced clinic alternatives are out of reach long-term. TRIMI's telehealth model was designed with exactly this gap in mind.
Miami GLP-1 Snapshot
Population: ~440,000 city / ~6.2 million metro (Miami-Dade + Broward + Palm Beach). Florida obesity rate: ~28%. Uninsured rate: ~18% (Miami-Dade). Typical clinic rate: $300–600/mo. Brand Wegovy: $1,000–$1,400/mo. TRIMI telehealth: $99/mo semaglutide, $125/mo tirzepatide.
Miami's diverse, largely bilingual population also highlights a healthcare access challenge: many residents — particularly in Little Havana, Hialeah, and Liberty City — face cultural and language barriers to navigating the specialty healthcare system. Telehealth, with its asynchronous intake process and straightforward digital interface, lowers many of these barriers simultaneously.
Local Clinic vs. Telehealth: Pricing Comparison
Miami's premium wellness clinic market is among the most expensive in the country for GLP-1 programs. Clinic packages in Brickell and Miami Beach regularly exceed $500/month when consultation fees, monitoring visits, and medication are bundled together.
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| Miami Weight Loss Clinic (avg) | $300–$600 | Yes | Sometimes |
| Brand Wegovy (no insurance) | $1,000–$1,400 | Yes | Recommended |
| TRIMI Telehealth (compounded) | $99/mo (sema) / $125/mo (tirz) | No | No |
Over a 12-month treatment course, choosing TRIMI at $99/month over a mid-range Miami clinic at $400/month saves $3,612. That's money that stays in your pocket — not paying for South Beach office real estate.
How Telehealth Works: Consultation to Delivery in Miami
Step 1: Online Health Intake
Complete a secure health questionnaire from your Miami home or office. Covers medical history, current medications, and weight loss goals. Takes about 10 minutes.
Step 2: Florida Provider Review
A licensed Florida provider evaluates your intake, confirms GLP-1 eligibility, and creates a starting dose plan — typically within 24–48 hours of submission.
Step 3: Prescription to Pharmacy
Prescription sent to a licensed 503A/503B compounding pharmacy. Semaglutide $99/mo or tirzepatide $125/mo — no insurance approval, no prior authorization.
Step 4: Delivered to Your South Florida Door
Temperature-controlled shipping arrives at any Miami-Dade, Broward, or Palm Beach address within 3–5 business days. Ongoing care managed through the TRIMI platform.
Available Medications
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- Weekly self-injection
- ~15% average weight loss at 68 weeks
- No insurance required
Compounded Tirzepatide
$125/month
- Dual GLP-1/GIP receptor agonist
- Weekly self-injection
- ~22% average weight loss at 72 weeks
- No insurance required
Review the full semaglutide vs. tirzepatide comparison to choose the right medication, or use the GLP-1 medication quiz for a personalized recommendation.
Miami's Health Landscape and GLP-1 Need
Florida's obesity rate is approximately 28%, somewhat lower than states like Texas and Georgia — but the Miami metro has its own specific health challenges. Type 2 diabetes is particularly prevalent among Miami's large Cuban American and Central American communities. The city's Jackson Memorial Hospital and University of Miami Health System are major regional research centers for metabolic disease, and their clinical research has contributed to the evidence base for GLP-1 treatment.
For Miami's working-class residents — those in Hialeah, Westchester, Homestead, and the Overtown neighborhood — the $300–600/month price tag of local GLP-1 clinic programs represents a real hardship. At $99/month, TRIMI makes a medically meaningful treatment financially viable for a far larger segment of South Florida's population.
Learn more about the cardiovascular benefits of GLP-1 medications and why these treatments are increasingly considered a standard of care, not just a lifestyle choice.
Getting Started with TRIMI in Miami
Miami-area residents who meet standard GLP-1 eligibility criteria — a BMI of 27 or higher with at least one weight-related condition, or a BMI of 30 or higher — can start the TRIMI process in about 10 minutes online. Your first delivery arrives within 3–5 business days anywhere in South Florida.
Read our guide on whether you're a candidate for GLP-1 treatment and check our pharmacy safety standards overview before starting.
Ready to Start in Miami?
Get compounded semaglutide delivered to any South Florida address for $99/month — temperature-controlled shipping, no clinic visit, no insurance required.
Get Started for $99/MonthMedical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- Florida Department of Health. Florida BRFSS: Obesity and Chronic Disease Data. 2023.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).